Additional features
-
Night mode
SOCIETY | 12:21 / 18.09.2024
709
1 min read
Pharmaceutical company fined 68 million UZS for counterfeit Imudon production
A company involved in the production of a counterfeit version of the medicine Imudon has been fined 68 million UZS.
Abbott Products Operations AG filed a complaint with the Ministry of Justice against the manufacturer of the counterfeit version of its drug Imudon.
During an inspection of the enterprise "LLC A," it was discovered that a product under the name Nest Imudon was being produced, which closely resembled the original Imudon drug.
It is noted that the director of "LLC A," S.F., had previously been held administratively liable for the production and sale of a counterfeit version of the drug Magne B6. As a result, "LLC A" was fined 68 million UZS.
Related News
15:32 / 21.11.2024
Rising synthetic drug use among students in Tashkent sparks concern
14:55 / 20.11.2024
Competition Committee uncovers massive price violations in pharmacies across Uzbekistan
14:57 / 19.11.2024
Law enforcement officers confiscate over 255 kg of drugs worth 161 billion UZS
15:06 / 04.11.2024